Skip to content

Clinical trials

Phase 3 Thrombocytopenia trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocytopenia Phase: Phase 3 Country / region: Germany Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20062
20091
20121
20132
20143

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline3
CTI BioPharma2
Eisai Inc.2
Novartis Pharmaceuticals2
CSL Behring1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombocytopenia10
Purpura, Thrombocytopenic, Idiopathic4
Anemia2
Bone Marrow Diseases2
Hematologic Diseases2
Myeloproliferative Disorders2
Polycythemia Vera2
Primary Myelofibrosis2
Purpura2
Splenomegaly2

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.